Table 2.
Function/Pathway | Gene sets enriched in sensitive patients | Size | NES | NOM p-val |
---|---|---|---|---|
p53 response | STRESS_ARSENIC_SPECIFIC_UP | 6 | 1.76 | 0.002 |
P53PATHWAY | 6 | 1.61 | 0.004 | |
HSA04115_P53_SIGNALING_PATHWAY | 13 | 1.62 | 0.006 | |
P53GENES_ALL | 9 | 1.53 | 0.021 | |
P53_BRCA1_UP | 5 | 1.50 | 0.030 | |
STRESS_P53_SPECIFIC_UP | 5 | 1.44 | 0.031 | |
KANNAN_P53_UP | 9 | 1.51 | 0.032 | |
DNA damage response | DNA_DAMAGE_SIGNALING | 13 | 1.69 | 0.008 |
UVC_TTD-XPCS_COMMON_DN | 8 | 1.69 | 0.014 | |
CIS_XPC_DN | 10 | 1.73 | 0.017 | |
DNA repair, cell cycle, apoptosis | BLEO_HUMAN_LYMPH_HIGH_4HRS_UP | 9 | 1.59 | 0.028 |
BAFF/APRIL receptor | MOREAUX_TACI_HI_VS_LOW_UP | 8 | 1.45 | 0.023 |
hTERT-regulated genes | SMITH_HTERT_DN | 5 | 1.57 | 0.028 |
ROTH_HTERT_DIFF | 7 | 1.48 | 0.049 | |
NF-KB signaling | HINATA_NFKB_UP | 6 | 1.53 | 0.032 |
Cell death | APOPTOSIS | 6 | 1.55 | 0.034 |
BRENTANI_DEATH | 6 | 1.55 | 0.034 | |
APOPTOSIS_GENMAPP | 5 | 1.56 | 0.035 | |
Cell cycle | CELL_CYCLE_KEGG | 6 | 1.52 | 0.044 |
CELL_CYCLE | 6 | 1.52 | 0.044 | |
TAKEDA_NUP8_HOXA9_16D_DN | 11 | 1.43 | 0.045 | |
Function/Pathway | Gene sets enriched in resistant patients | Size | NES | NOM p-val |
T lymphocyte proliferation | GOLDRATH_HP | 14 | 1.61 | 0.008 |
EGR2-regulated genes | LE_MYELIN_UP | 6 | 1.58 | 0.009 |
Genes involved in cholera infection | HSA05110_CHOLERA_INFECTION | 5 | 1.63 | 0.023 |
Myeloma cell growth and survival | CHAUHAN_2ME2 | 5 | 1.50 | 0.042 |
DNA and RNA metabolism | WERNER_FIBRO_DN | 5 | 1.45 | 0.059 |
p53 response, anti-apoptosis, DNA repair | UVB_SCC_DN | 6 | 1.39 | 0.086 |
Myc-regulated genes | MYC_ONCOGENIC_SIGNATURE | 8 | 1.37 | 0.061 |
Functions of mature T lymphocytes | LEE_TCELLS2_UP | 46 | 1.27 | 0.084 |
Hematopoeitic stem cell genes | BYSTRYKH_HSC_TRANS_GLOCUS | 29 | 1.38 | 0.070 |
APC-regulated genes | SANSOM_APC_LOSS5_UP | 10 | 1.47 | 0.084 |
NES Normalized Enrichment Score, NOM p-val Nominal p-value